Wave Life Sciences WVE Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $189.6M+13.6% | $182.78M+14.5% | $174.61M+17.1% | $169.93M+21.8% | $166.86M+26.0% | ||
| $79.08M+23.9% | $75.33M+27.6% | $70.57M+24.8% | $67.52M+23.6% | $63.83M+21.3% | ||
| $268.68M+16.5% | $258.11M+18.0% | $245.18M+19.2% | $237.46M+22.3% | $230.69M+24.6% | ||
| -$196.88M— | -$215.38M— | —— | —— | —— | ||
| $13.29M-1.0% | $11.01M-17.8% | $14M+46.9% | $13.64M+43.1% | $13.42M+36.6% | ||
| -$183.59M— | -$204.38M— | —— | —— | —— | ||
| $0— | $0— | $0— | $0+100% | $0+100% | ||
| -$183.59M— | -$204.38M— | —— | —— | —— | ||
| -$1.05— | -$1.21— | —— | —— | —— | ||
| -$193.47M— | -$211.94M— | —— | —— | —— | ||
| -$196.88M— | -$215.38M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Wave Life Sciences's revenue?
- Wave Life Sciences (WVE) generated $75.8M in revenue over the trailing twelve months, down 32.9% year over year.
- Is Wave Life Sciences profitable?
- Wave Life Sciences is not currently profitable: it reported a net loss of $183.6M over the trailing twelve months, a -66.5% net margin.
- What is Wave Life Sciences's earnings per share?
- Wave Life Sciences's diluted EPS over the trailing twelve months is $-1.05.
- Where does Wave Life Sciences's income statement data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
